Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy
NCT00346853
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Macular Dystrophy, Corneal
Interventions
DRUG:
4-Methylpyrazole
OTHER:
saline
Sponsor
University of Utah